Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
Crossref DOI link: https://doi.org/10.1186/S12885-017-3150-7
Published: 2017-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Luo, Yanji
Chen, Jie
Huang, Kun
Lin, Yuan
Chen, Minhu
Xu, Ling
Li, Zi-Ping
Feng, Shi-Ting
Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2014A030310484)
National Natural Science Foundation ofChina (CN) (81571750)
